GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $33.24 $45.00 Friday, 19th Apr 2024 CRBP stock ended at $39.24. This is 7.42% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 11.37% from a day low at $35.79 to a day high of $39.86.
90 days $6.63 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
2024-04-19 $35.79 $39.86 $35.79 $39.24 278 002
2024-04-18 $36.17 $37.78 $35.26 $36.53 127 788
2024-04-17 $41.12 $41.12 $36.09 $37.16 417 654
2024-04-16 $42.71 $45.00 $40.96 $41.12 351 751
2024-04-15 $40.68 $42.96 $39.58 $42.72 334 150
2024-04-12 $39.65 $40.99 $39.17 $40.85 291 611
2024-04-11 $38.10 $40.15 $37.00 $40.00 186 323
2024-04-10 $36.03 $38.56 $35.50 $38.15 65 871
2024-04-09 $40.33 $40.89 $36.01 $37.47 222 997
2024-04-08 $40.06 $42.20 $37.50 $40.16 205 880
2024-04-05 $39.62 $40.35 $38.81 $39.97 151 138
2024-04-04 $39.59 $40.67 $38.77 $38.97 161 276
2024-04-03 $37.01 $40.29 $37.01 $38.50 194 749
2024-04-02 $37.21 $40.64 $35.80 $37.46 213 679
2024-04-01 $39.24 $40.94 $37.99 $37.99 172 706
2024-03-28 $35.42 $39.96 $35.16 $39.24 234 856
2024-03-27 $36.03 $36.53 $33.24 $35.57 173 999
2024-03-26 $35.42 $38.24 $35.34 $36.15 239 511
2024-03-25 $35.80 $36.56 $35.00 $35.63 235 828
2024-03-22 $37.02 $38.00 $34.44 $34.94 184 862
2024-03-21 $38.70 $39.46 $37.26 $38.15 293 917
2024-03-20 $42.56 $43.76 $38.65 $39.17 265 263
2024-03-19 $39.50 $43.86 $39.50 $42.76 122 495
2024-03-18 $43.13 $43.13 $39.01 $41.62 236 403
2024-03-15 $45.55 $46.74 $42.28 $43.68 489 557
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT